Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-20-024872

Chairman and CEO acquired 100,000 shares (grant or award)

  • Chairman and CEO gave up 37,209 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KAZIMI A J Chairman and CEO 2020-03-18 Shares withheld for taxes −37,209 $3.53 $131,348 5,690,407 D
KAZIMI A J Chairman and CEO 2020-03-23 Grant or award +100,000 $3.56 $356,000 5,790,407 D
Loading xslF345X03/doc4.xml…